<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950623/" ref="ordinalpos=3411&amp;ncbi_uid=5930161&amp;link_uid=PMC3950623" image-link="/pmc/articles/PMC3950623/figure/Fig8/" class="imagepopup">Fig. 8.  From: Opposing <span class="highlight" style="background-color:">Signaling</span> of ROCK1 and ROCK2 Determines the Switching of Substrate Specificity and the Mode of Migration of Glioblastoma Cells. </a></div><br /><div class="p4l_captionBody">Second part of signaling pathway analyses of cells with altered ROCK1 and ROCK2 expressions. Here, we analyzed the protein expression of RhoA (<b>d</b>), β1-integrin (<b>e</b>), β-catenin (f), pERK1 (<b>g</b>), and pERK2 (<b>h</b>) using densitometric measurement in cells with ROCK1 knockdown (<b>a</b>), ROCk2 knockdown (<b>b</b>), and cells treated with Rho kinase inhibitor Y27632 (<b>c</b>)</div></div>